Sixth follow-up: Whole-body CT showed no signs of recurrence or metastasis. Tumor marker levels: AFP, 2.9 ng/mL; CEA, 4.6 ng/mL; CA19-9, 16.3 U/mL; CA72-4, 12.75 U/mL. This evidence concerns the gene AFP and neoplasm.